BE863810A - Procede de preparation d'un antigene et d'un anticorps - Google Patents

Procede de preparation d'un antigene et d'un anticorps

Info

Publication number
BE863810A
BE863810A BE185040A BE185040A BE863810A BE 863810 A BE863810 A BE 863810A BE 185040 A BE185040 A BE 185040A BE 185040 A BE185040 A BE 185040A BE 863810 A BE863810 A BE 863810A
Authority
BE
Belgium
Prior art keywords
antigen
antibody
preparing
Prior art date
Application number
BE185040A
Other languages
English (en)
French (fr)
Inventor
T Nishino
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BE863810A publication Critical patent/BE863810A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE185040A 1977-02-10 1978-02-09 Procede de preparation d'un antigene et d'un anticorps BE863810A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52013919A JPS5836308B2 (ja) 1977-02-10 1977-02-10 抗体の製造方法

Publications (1)

Publication Number Publication Date
BE863810A true BE863810A (fr) 1978-05-29

Family

ID=11846569

Family Applications (1)

Application Number Title Priority Date Filing Date
BE185040A BE863810A (fr) 1977-02-10 1978-02-09 Procede de preparation d'un antigene et d'un anticorps

Country Status (8)

Country Link
US (2) US4221777A (enExample)
JP (1) JPS5836308B2 (enExample)
BE (1) BE863810A (enExample)
DE (1) DE2805663B2 (enExample)
DK (1) DK157340C (enExample)
FR (1) FR2380296A1 (enExample)
GB (1) GB1580582A (enExample)
SE (1) SE427931B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon
JPS5657753A (en) * 1979-10-16 1981-05-20 Toyo Jozo Co Ltd Novel glucagon fragment, and its use
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
JPS5735551A (en) * 1980-08-08 1982-02-26 Daiichi Rajio Isotope Kenkyusho:Kk Preparation of undecapeptide
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
FR2525592B1 (enExample) * 1982-04-26 1984-09-14 Pasteur Institut
US4487715A (en) * 1982-07-09 1984-12-11 The Regents Of The University Of California Method of conjugating oligopeptides
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
EP0134868A1 (en) * 1983-08-26 1985-03-27 Anda Biologicals Unicellular organisms activated by glutaraldehyde as solid carriers for sensitizing agents and uses of sensitized unicellular organisms
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
US4731439A (en) * 1985-11-22 1988-03-15 Oncogen Snake venom growth arresting peptide
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
US5176227A (en) * 1991-08-01 1993-01-05 Tec Tran Corporation Railway service and parking brake actuator
US5253736A (en) * 1991-08-01 1993-10-19 Tec Tran Corporation Railway brake actuator
US20050009205A1 (en) * 2003-07-11 2005-01-13 Ye Fang Fluorescent ligands for GPCR arrays
BR112017005110A2 (pt) 2014-09-16 2018-01-23 Regeneron Pharma anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo, molécula isolada de ácido nucleico, composição farmacêutica, e, método para diminuir níveis de glicose no sangue ou para tratar uma condição ou doença.
JP7173962B2 (ja) 2016-08-30 2022-11-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド グルカゴン受容体シグナル伝達の干渉による重度のインスリン抵抗性の処置方法
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
CA3071387A1 (en) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
CN114410590B (zh) * 2022-01-27 2024-01-09 广州市进德生物科技有限公司 一种分泌胰高血糖素单克隆抗体杂交瘤细胞株及其单克隆抗体与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553310A (en) * 1967-12-28 1971-01-05 Miles Lab Immunologically reactive particles
CH453269A4 (enExample) * 1968-03-29 1973-01-31
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US3975342A (en) * 1972-05-15 1976-08-17 Biological Developments, Inc. Tyrosyl-class antigenic conjugates, their preparation and antibodies raised thereto
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay

Also Published As

Publication number Publication date
SE7801545L (sv) 1978-08-11
DK157340B (da) 1989-12-18
JPS5836308B2 (ja) 1983-08-08
US4221777A (en) 1980-09-09
DE2805663C3 (enExample) 1980-11-13
GB1580582A (en) 1980-12-03
FR2380296B1 (enExample) 1981-07-10
DE2805663A1 (de) 1978-08-17
FR2380296A1 (fr) 1978-09-08
JPS5399320A (en) 1978-08-30
DK157340C (da) 1990-05-14
SE427931B (sv) 1983-05-24
US4272433A (en) 1981-06-09
DE2805663B2 (de) 1980-03-13
DK59778A (da) 1978-08-11

Similar Documents

Publication Publication Date Title
SG57984G (en) Immunoassay for class specific antibodies
IL55816A0 (en) Method for simultanesous immunoassay of several different antibodies
BE866226A (fr) Procede pour la preparation de thymosine alpha1 et d'un analogue
NO792822L (no) Antigen-preparat og fremgangsmaate for fremstilling derav
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
LU81482A1 (fr) Procede de preparation de d-camphorate de l-carnitinamide et de d-camphorate de d-carnitinamide
SE7801545L (sv) Forfarande for framstellning av antigen och antikropp
BE866096A (fr) Antigene du noyau d'hepatite b et procede pour sa preparation
BE871338A (fr) Procede et appareil de preparation d'une suspension
ZA79893B (en) Novel antigen derivatives and process for their manufacture
LU81086A1 (fr) Procede de preparation de tetrahydrobenzoxocines et de cis-hexahydrodibenzopyranones
GB2015156B (en) Determination of antigens of antibodies
BE888906A (fr) Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
BE871107A (fr) Antigene pour un test de detection precoce de la grossesse et un vaccin contraceptif
IT7848508A0 (it) Antigeni e anticorpi della teofillina
JPS54140717A (en) Producing of human antibody
IT1074325B (it) Antigene tumorale e processo per la sua preparazione
BE857327A (fr) Procede d'isolement et de recuperation d'hormones proteiques
DE3373214D1 (en) Method of measuring infectious disease antibodies
BE846822A (fr) Procede pour deceler l'antigene et les anticorps de l'hepatite et vaccin contre l'hepatite
BE839836A (fr) Procede de preparation du tricosene-(9) et de l'heneicosene-(9)
PT86117A (fr) Anticorps monoclonaux antigram (-), procede de preparation et applications
BE872294A (fr) Procede de preparation de 3-iodorifamycine s et de 3-bromorifamycine s
BE858406A (fr) Nouveau procede de dosage d'antigenes et d'anticorps
FR2500754B1 (fr) Anticorps monoclonaux

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: OTSUKA PHARMACEUTICAL CO. LTD

Effective date: 19980209